mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |